Diseases, Conditions, Syndromes

Hypoferremia predicts treatment response to IFN-α

(HealthDay) -- For patients with hepatitis C virus (HCV), hepcidin, a regulator of iron homeostasis, is induced following a single dose of pegylated interferon-α (PEG-IFNα), and may be a surrogate marker of immediate ...

Health

Overcrowding in prisons negatively affects health

an issue in most prisons in Canada and other parts of the world—negatively impacts the mental and physical health of prisoners, states an article in CMAJ (Canadian Medical Association Journal).

Diseases, Conditions, Syndromes

Researchers find clue to how Hepatitis C virus harms liver

Researchers at the University of Southern California (USC) have discovered a trigger by which the Hepatitis C virus enters liver cells ─ shedding light on how this serious and potentially deadly virus can begin to damage ...

Diseases, Conditions, Syndromes

Chronic hepatitis C: Interferon may be harmful in re-treatment

People with hepatitis C and chronic liver disease who relapsed or failed to respond to initial treatment are unlikely to improve on interferon retreatment. In fact, they may face an increased risk of dying sooner, and are ...

Diseases, Conditions, Syndromes

Hepatitis C deaths up, baby boomers most at risk

(AP) -- Deaths from liver-destroying hepatitis C are on the rise, and new data shows baby boomers especially should take heed - they are most at risk.

Medications

Scientists design new drug compound to stop malaria in its tracks

Researchers at the Francis Crick Institute and the Latvian Institute of Organic Synthesis have designed a drug-like compound which effectively blocks a critical step in the malaria parasite life cycle and are working to develop ...

page 5 from 35